ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS
Application
US20260083679A1
Kind: A1
Mar 26, 2026
Inventors
Cletus Nunes, Mehrdad Kheiripour, Monika Gavireddi
Abstract
Pharmaceutical compositions in solid form comprising adagrasib, suitable for oral dosage to treat subjects having cancer; as well as methods of manufacturing the compositions, and methods of treating cancer.
CPC Classifications
A61K 9/2054
A61K 9/0053
A61K 9/2009
A61K 9/2013
A61K 9/2018
A61K 9/2027
A61K 9/28
A61K 31/519
Filing Date
2025-12-03
Application No.
19407221